Source:http://linkedlifedata.com/resource/pubmed/id/16455967
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-2-3
|
pubmed:abstractText |
Mouse mast cell development and survival are largely controlled by the cytokines IL-3 and stem cell factor (SCF). We have found that IL-3 stimulation of bone marrow cells induces the production of TNF via a PI3K- and MAPK kinase/ERK-dependent pathway. Specifically, Mac-1-positive cells were responsible for TNF production, which peaked on days 7-10 of culture and decreased rapidly thereafter. The importance of IL-3-induced TNF secretion was demonstrated by the failure of TNF-deficient bone marrow cells to survive for >3 wk when cultured in IL-3 and SCF, a defect that was reversed by the addition of soluble TNF. The development of human mast cells from bone marrow progenitors was similarly hampered by the addition of TNF-blocking Abs. Cell death was due to apoptosis, which occurred with changes in mitochondrial membrane potential and caspase activation. Apoptosis appeared to be due to loss of IL-3 signaling, because TNF-deficient cells were less responsive than their wild-type counterparts to IL-3-mediated survival. In vitro cultured mast cells from TNF-deficient mice also demonstrated reduced expression of the high affinity IgE receptor, which was restored to normal levels by the addition of soluble TNF. Finally, TNF-deficient mice demonstrated a 50% reduction in peritoneal mast cell numbers, indicating that TNF is an important mast cell survival factor both in vitro and in vivo.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
176
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2114-21
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16455967-Animals,
pubmed-meshheading:16455967-Bone Marrow,
pubmed-meshheading:16455967-Bone Marrow Cells,
pubmed-meshheading:16455967-Cell Differentiation,
pubmed-meshheading:16455967-Cell Lineage,
pubmed-meshheading:16455967-Cell Survival,
pubmed-meshheading:16455967-Cells, Cultured,
pubmed-meshheading:16455967-Humans,
pubmed-meshheading:16455967-Interleukin-3,
pubmed-meshheading:16455967-Macrophage-1 Antigen,
pubmed-meshheading:16455967-Macrophages,
pubmed-meshheading:16455967-Mast Cells,
pubmed-meshheading:16455967-Mice,
pubmed-meshheading:16455967-Tumor Necrosis Factor-alpha
|
pubmed:year |
2006
|
pubmed:articleTitle |
IL-3-mediated TNF production is necessary for mast cell development.
|
pubmed:affiliation |
Department of Biology, Virginia Commonwealth University, Richmond, 23284, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|